Title: Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain ‐ Possible Relations to its Psychotropic Actions ‐: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus
Abstract: Pharmacology & ToxicologyVolume 73, Issue S3 p. 1-47 Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain - Possible Relations to its Psychotropic Actions -: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus Arne Mørk, Arne Mørk Department of Pharmacology, University of CopenhagenSearch for more papers by this author Arne Mørk, Arne Mørk Department of Pharmacology, University of CopenhagenSearch for more papers by this author First published: November 1993 https://doi.org/10.1111/j.1600-0773.1993.tb01704.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Alhaider AA, Mustafa AA. Enhancement of imipramine-induced rat brain ß-adrenoceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan. Psychopharmacology 1991, 103: 351–356. Alousi AA, Jasper JR, Insel PA, Motulsky HJ. Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 1991, 5: 2300–2003. Andersen PH, Geisler A. Lithium inhibition of forskolin-stimulated adenylate cyclase. Neuropsychobiology 1984, 12: 1–3. Andersen PH, Geisler A, Klysner R. No change in rat cerebral cortex calmodulin content following chronic treatment with lithium, reserpine, imipramine, and lithium combined with reserpine or imipramine. Acta pharmacol et toxicol 1984, 54: 394–399. Austin M-PV, Souza FGM, Goodwin GM. Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Brit J Psychiatry 1991, 159: 510–514. Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988, 331: 440–442. Avissar S, Schreiber G. Muscarinic receptor subclassification and G-proteins: significance for lithium action in affective disorders and the treatment of the extrapyramidal side effects of neuroleptics. Biol Psychiatry 1989, 26: 113–130. Avissar S, Murphy DL, Schreiber G. Magnesium reversal of lithium inhibition of ß-adrenergic and muscarinic receptor coupling to G proteins. Biochem Pharmacol 1991, 41: 171–175. Baastrup PC, Schou M. Lithium as a prophylactic agent. Arch Gen Psychiatry 1967, 16: 162–172. Bakalyar HA, Reed RR. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science 1990, 250: 1403–1406. Baron BM, Ogden A-M, Siegel BW, Stegeman J, Ursillo RC, Dudley MW. Rapid down regulation of ß-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 1988, 154: 125–134. Barrett D, Breslau NA, Wax MB, Molinoff PB, Downs, Jr. RW. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol 1989, 257: E277–E283. Bartfai T. Preparation of metal-chelate complexes and the design of steady-state kinetic experiments involving metal nucleotide complexes. In: Advances in cyclic nucleotide research, vol. 10 (Eds. G Brooker, P Greengard, G.A. Robison), Raven Press, New York, 1979, 219–242. Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV. Effects of xanthine derivates on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol 1970, 6: 597–603. Belmaker RH, Hamburger-Bar R, Newman M, Bannet J. The effect of rubidium and lithium on adenylate cyclase and neurotransmitter receptors. In: Current trends in lithium and rubidium therapy (Ed. GU Corsini), MTP Press, Lancaster, 1984, 59–75. Bender JL, Neer EJ. Properties of the adenylate cyclase catalytic unit from caudate nucleus. J Biol Chem 1983, 258: 2432–2439. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982, 206: 587–595. Birch NJ. Magnesium and psychiatry: biochemistry and inorganic pharmacology related to lithium. In: Magnesium in cellular processes and medicine (Eds. BM Altura, J Durlach, MS Seelig), Karger, Basel, 1987, 212–218. Birch NJ. Lithium in the cellular environment. In: Lithium and the cell: pharmacology and biochemistry (Ed. NJ Birch), Academic Press, London, 1991, 159–173. Birnbaumer L, Abramowitz J, Yatani A, Okabe K, Mattera R, Graf R, Sanford J, Codina J, Brown AM. Roles of G proteins in coupling of receptors to ionic channels and other effector systems. Crit Rev Biochem Mol Biol 1990, 25: 225–244. Birnbaumer L, Perez-Reyes E, Bertrand P, Gudermann T, Wei X-Y, Kim H, Castellano A, Codina J. Molecular diversity and function of G proteins and calcium channels. Biol Reproduction 1991, 44: 207–224. Blier P, De Montigny C, Tardif D. Short-term lithium treatment enhances responsiveness of postsynaptic 5-HT1A receptors without altering 5-HT autoreceptor sensitivity: An electrophysiological study in the rat. Synapse 1987, 1: 225–232. Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN. Piperazine derivates including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 1987, 335: 588–592. Bonate PL. Serotonin receptor subtypes: functional, physiological, and clinical correlates. Clin Neuropharmacol 1991, 14: 1–16. Bouhelal R, Smounya L, Bockaert J. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur J Pharmacol 1988, 151: 189–196. Bouthillier A, Blier P, De Montigny C. Flerobuterol, a ß-adrenoceptor agonist, enhances serotonergic neurotransmission: an electrophysiological study in the rat brain. Psychopharmacology 1991, 103: 357–365. Bouvier M, Hausdorff WP, De Blasi A, O'Dowd BF, Kobilka BK, Caron MG, Lefkowitz RJ. Removal of phosphorylation sites from the beta2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 1988, 333: 370–373. Bouvier M, Guilbault N, Bonin H. Phorbol-ester-induced phosphorylation of the beta2-adrenergic receptor decreases its coupling to Gs. FEBS Lett 1991, 279: 243–248. Bradham LS. Comparison of the effects of Ca2+ and Mg2+ on the adenyl cyclase of beef brain. Biochim Biophys Acta 1972, 276: 434–443. Bradham LS, Hegazy MG. Separation of the catalytic and stimulatory regulatory subunits of rat brain adenylate cyclase. J Cyc Nucl Prot Phosphor Res 1983, 9: 331–340. Broaddus WC, Vauquelin G, Maguire ME. Sealed membrane vesicle preparation from S49 lymphoma cells and demonstration that GTP and Mg2+ act at the cytoplasmic membrane face. In: Advances in cyclic nucleotide research. ( J.E. Dumont, P. Greengard & G.A. Robison), Raven Press, New York, 1981, 656. Brostrom MA, Brostrom CO, Wolff DJ. Calcium-dependent adenylate cyclase from rat cerebral cortex: activation by guanine nucleotides. Arch Biochem Biophys 1978, 191: 341–350. Brunello N, Barbaccia ML, Chuang D-M, Costa E. Down-regulation of ß-adrenergic receptors following repeated injections of desmethylimipramine: Permissive role of serotonergic axons. Neuropharmacology 1982, 21: 1145–1149. Bunney, Jr. WE, Davis JM. Norepinephrine in depressive reactions. Arch Gen Psychiatry 1965, 13: 483–494. Bunney, Jr. WE, Garland BL. Possible receptor effects of chronic lithium administration. Neuropharmacology 1983, 22: 367–372. Byerley WF, McConnell EJ, McCabe RT, Dawson TM, Grosser BI, Wamsley JK. Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine. Psychopharmacology 1988, 94: 141–143. Cade JFJ. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949, 2: 349–352. Caldecott-Hazard S, Guze BH, Kling MA, Kling A, Baxter LR. Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques. Synapse 1991a, 8: 185–211. Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 1991b, 9: 251–301. Carman JS, Wyatt RJ. Calcium: bivalent cation in the bivalent psychoses. Biol Psychiatry 1979, 14: 295–336. Casebolt TL, Jope RS. Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry 1991, 29: 233–243. Cech SY, Broaddus WC, Maguire ME. Adenylate cyclase: The role of magnesium and other divalent cations. Mol Cell Biochem 1980, 33: 67–92. Cech SY, Maguire ME. Magnesium regulation of the beta-receptor-adenylatecyclase complex. I. Effects of manganese on receptor binding and cyclase activation. Mol Pharmacol 1982, 22: 267–273. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischemic injury. N Engl J Med 1986, 314: 1670–1676. Cheung WY, Bradham LS, Lynch TJ, Lin YM, Tallant EA. Protein activator of cyclic 3′:5′-nucleotidephosphodiesterase of bovine or rat brain also activates its adenylate cyclase. Biochem Biophys Res Commun 1975, 66: 1055–1062. Choi EJ, Toscano, Jr. WA. Modulation of adenylate cyclase in human keratinocytes by protein kinase C. J Biol Chem 1988, 263: 17167–17172. Christensen S, Kusano E, Yusufi ANK, Murayama N, Dousa TP. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 1985, 75: 1869–1979. Codina J, Hildebrandt JD, Sekura RD, Birnbaumer M, Bryan J, Manclark CR, Iyengar R, Birnbaumer L. Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. J Biol Chem 1984a, 259: 5871–5886. Codina J, Hildebrandt JD, Birnbaumer L. Effects of guanine nucleotides and Mg on human erythrocyte Ni and Ns, the regulatory components of adenylyl cyclase. J Biol Chem 1984b, 259: 11408–11418. Cogan E, Abramow M. Inhibition by lithium of the hydro-osmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit. J Clin Invest 1986, 77: 1507–1514. Colin SF, Chang H-C, Mollner S, Pfeuffer T, Reed RR, Duman RS, Nestler EJ. Chronic lithium regulates the expression of adenylate cyclase and Gi-protein α subunit in rat cerebral cortex. Proc Natl Acad Sci USA 1991, 88: 10634–10637. Conn PJ, Sanders-Bush E. Agonist-induced phosphoinositide hydrolysis in choroid plexus. J Neurochem 1986, 47: 1754–1760. Conn PJ, Sanders-Bush E. Central serotonin receptors: effector systems, physiological roles and regulation. Psycho-pharmacology 1987, 92: 267–277. Cooper DMF, Ahlijanian MK, Perez-Reyes E. Calmodulin plays a dominant role in determining neurotransmitter regulation of neuronal adenylate cyclase. J Cell Biochem 1988, 36: 417–427. Cooper DMF, Boyajian CL, Goldsmith PK, Unson CG, Spiegel A. Differential expression of low molecular weight form of Gs-α in neostriatum and cerebellum: correlation with expression of calmodulin-independent adenylyl cyclase. Brain Res 1990, 523: 143–146. Costa E, Garattini S, Valzelli L. Interactions between reserpine, chlorpromazine, and imipramine. Experientia 1960, 16: 461–463. Coussen F, Haiech J, D'Alayer J, Monneron A. Identification of the catalytic subunit of brain adenylate cyclase: A calmodulin binding protein of 135 kDa. Proc Natl Acad Sci USA 1985, 82: 6736–6740. Cowburn RF, Garlind A, O'Neill C, Alafuzoff I, Winblad B, Fowler CJ. Characterization and regional distribution of adenylyl cyclase activity from human brain. Neurochem Int 1991, 18: 389–398. Cowen PJ. Serotonin receptor subtypes: implications for psychopharmacology. Brit J Psychiatry 1991, 159 (suppl. 12): 7–14. Davies AO, Jian Su C, Balasubramanyam A, Codina J, Birnbaumer L. Abnormal guanine nucleotide regulatory protein in MVP dysautonomia: evidence form reconstitution of Gs. J Clin Endocrinol Metab 1991, 72: 867–875. De Keyser J, Dierckx R, Vanderheyden P, Ebinger G, Vauquelin G. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation. Brain Res 1988, 443: 77–84. De Montigny C, Cournoyer G, Morissette R, Langlois R, Caille G. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Arch Gen Psychiatry 1983, 40: 1327–1334. De Paermentier F, Cheetham SC, Crompton MR, Katona CLE, Horton RW. Brain ß-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res 1990, 525: 71–77. De Paermentier F, Cheetham SC, Crompton MR, Katona CLE, Horton RW. Brain ß-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment. Psychopharmacology 1991, 105: 283–288. De Vivo M, Maayani S. Characterization of the 5-hydroxy-tryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 1986, 238: 248–253. Downes CP, Stone MA. Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland. Biochem J 1986, 234: 199–204. Dubovsky SL, Franks RD. Intracellular calcium ions in affective disorders: a review and an hypothesis. Biol Psychiatry 1983, 18: 781–797. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Ardon Harris R. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry 1989, 46: 632–638. Dubovsky SL, Lee C, Christiano J, Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry 1991a, 29: 441–450. Dubovsky SL, Lee C, Christiano J, Murphy J. Lithium lowers platelet intracellular ion concentration in bipolar patients. Lithium 1991b, 2: 167–174. Duman RS, Strada SJ, Enna SJ. Effect of imipramine and adrenocorticotropin administration on the rat brain norepinephrine-coupled cyclic nucleotide generating system: alterations in alpha and beta adrenergic components. J Pharmacol Exp Ther 1985, 234: 409–414. Ebstein RP, Hermoni M, Belmaker RH. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther 1980, 213: 161–167. Ebstein RP, Moscovich D, Zeevi S, Amiri Z, Lerer B. Effect of lithium in vitro and after chronic treatment on human platelet adenylate cyclase activity: postreceptor modification of second messenger signal amplification. Psychiat Res 1987, 21: 221–228. Ebstein RP, Lerer B, Bennett ER, Shapira B, Kindler S, Shemesh Z, Gerstenhaber N. Lithium modulation of second messenger signal amplification in man: inhibition of phosphatidylinositol-specific phospholipase C and adenylate cyclase activity. Psychiat Res 1988, 24: 45–52. Egawa M, Hoebel BG, Stone EA. Use of microdialysis to measure brain noradrenergic receptor function in vivo. Brain Res 1988, 458: 303–308. Egeland JA Gerhard DS, Pauls DL, Sussex JN, Kidd KK, Allen CR, Hostetter AM, Housman DE. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 1987, 325: 783–787. Ellis J, Lenox RH. Receptor coupling to G proteins: interactions not affected by lithium. Lithium 1991, 2: 141–147. Enjalbert A, Bockaert J. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary. Mol Pharmacol 1983, 23: 576–584. Farfel Z, Brickman AS, Kaslow HR, Brothers VM, Bourne HR. Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. New Engl J Med 1980, 303: 237–242. Feinstein PG, Schrader KA, Bakalyar HA, Tang W-J, Krupinski J, Gilman AG, Reed RR. Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain. Proc Natl Acad Sci USA 1991, 88: 10173–10177. Florio VA, Sternweis PC. Mechanisms of muscarinic receptor action on G0 in reconstituted phospholipid vesicles. J Biol Chem 1989, 264: 3909–3915. Forn J, Valdecasas FG. Effects of lithium on brain adenylate cyclase activity. Biochem Pharmacol 1971, 20: 2773–2778. Fossel ET, Sarasua MM, Koehler KA. A lithium-7 NMR investigation of the lithium ion interaction with phosphatidylcholine-phosphatidylglycerol membranes. Observation of calcium and magnesium ion competition. J Magnet Reson 1985, 64: 536–540. Frizel D, Coppen A, Marks V. Plasma magnesium and calcium in depression. Brit J Psychiatry 1969, 115: 1375–1377. Gao B, Gilman AG. Cloning and expression of a widely distributed (type IV) adenylyl cyclase. Proc Natl Acad Sci USA 1991, 88: 10178–10182. Geisler A, Wraae O, Vendelin Olesen O. Adenyl cyclase activity in kidneys of rats with lithium-induced polyuria. Acta Pharmacol et toxicol 1972, 31: 203–208. Geisler A, Klysner R, Thams P, Christensen S. A simple and inexpensive protein binding assay for cyclic AMP in biological materials. Acta pharmacol et toxicol 1977, 40: 356–368. Geisler A, Klysner R, Andersen PH. Effect of treatment with lithium and antidepressants on beta-adrenoceptors and cyclic AMP accumulation in rat cerebral cortex. Acta Pharmacol et toxicol 1982, 51 (suppl. II): 18. Geisler A, Mørk A, Klysner R. Influence of lithium and other metal ions on adenylate cyclase activity. In: Drug receptors and dynamic processes in cells (Eds. JS Schou, A Geisler, S Norn), Munksgaard, Copenhagen, 1986, 302–318. Geisler A, Mørk A. The interaction of lithium with magnesium-dependent enzymes. In: Lithium and cell physiology (Eds. RO Bach, VS Gallicchio), Springer-Verlag, New York, 1990, 125–136. Gershon ES, Berrettini W, Nurnberger, Jr. J, Goldin LR. Genetics of affective illness. In: Psychopharmacology. The third generation of progress (Ed. HY Meltzer), Raven Press, New York, 1987, 481–491. Gershon ES, Martinez M, Goldin LR, Gejman PV. Genetic mapping of common diseases: the challenges of manic-depressive illness and schizophrenia. TIG 1990, 6: 282–287. Gillespie DD, Hal Manier D, Sanders-Bush E, Sulser F. The serotonin/norepinephrine-linkin brain.II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation. J Pharmacol Exp Ther 1988, 244: 154–159. Gilman AG. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J Clin Invest 1984, 73: 1–4. Gilman AG. G proteins: transducers of receptor-generated signals. Ann Rev Biochem 1987, 56: 615–649. Gilman AG. G proteins and regulation of adenylyl cyclase. J Am Med Assoc 1989, 262: 1819–1825. Giral P, Martin P, Soubrie P, Simon P. Reversal of helpless behavior in rats by putative 5-HT1A agonists. Biol Psychiatry 1988, 23: 237–242. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain - I. J Neurochem 1966, 13: 655–669. Gnegy ME, Muirhead N, Harrison JK. Regulation of calmodulin- and dopamine-stimulated adenylate cyclase activities by light in bovine retina. J Neurochem 1984, 42: 1632–1640. Goldberg H, Clayman P, Skorecki K. Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells. Am J Physiol 1988, 255: F995–F1002. Goodwin GM, De Souza RJ, Green AR. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology 1986, 90: 488–493. Goodwin GM. The effects of antidepressant treatments and lithium upon 5-HT1A receptor function. Prog Neuro-Psychopharmacol & Biol Psychiat 1989, 13: 445–451. Gross G, Dodt C, Hanft G. Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex. Naunyn-Schmiedeberg's Arch Pharmacol 1988, 337: 267–272. Gross G, Hanft G. Does lithium in vitro and ex vivo alter the release of [3H]noradrenaline from brain tissue and the sensitivity of presynaptic autoreceptors? Neuropharmacology 1990, 29: 831–835. Halbreich U, Rojansky N, Zander KJ, Barkai A. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J Psychiat Res 1991, 25: 7–18. Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980, 255: 10896–10901. Harrison JK, Mickevicius CK, Gnegy ME. Differential regulation by calmodulin of basal, GTP-, and dopamine-stimulated adenylate cyclase activities in bovine striatum. J Neurochem 1988, 51: 345–352. Harrison JK, Hewlett GHK, Gnegy ME. Regulation of calmodulin-sensitive adenylate cyclase by the stimulatory G-protein, Gs. J Biol Chem 1989, 264: 15880–15885. Hausdorff WP, Hnatowich M, O'Dowd BF, Caron MG, Lefkowitz RJ. A mutation of the ß2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. J Biol Chem 1990, 265: 1388–1393. Healy D, Carney PA, Leonard BE. Monoamine-related markers of depression: changes following treatment. J Psychiat Res 1983, 17: 251–260. Heideman W, Wierman BM, Storm DR. GTP is not required for calmodulin stimulation of bovine brain adenylate cyclase. Proc Natl Acad Sci USA 1982, 79: 1462–1465. Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 1983, 40: 1335–1342. Hensler JG, Ordway GA, Gambarana C, Areso P, Frazer A. Serotonergic neurons do not influence the regulation of beta adrenoceptors induced by either desipramine or isoproterenol. J Pharmacol Exp Ther 1991, 256: 656–664. Higashijima T, Ferguson KM, Sternweis PC, Smigel MD, Gilman AG. Effects of Mg2+ and the ßγ-subunit complex on the interactions of guanine nucleotides with G proteins. J Biol Chem 1987a, 262: 762–766. Higashijima T, Ferguson KM, Smigel MD, Gilman AG. The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of G0. J Biol Chem 1987b, 262: 757–761. Hirschfeld RMA, Cross CK. Clinical psychopathology and diagnosis in relation to treatment of affective disorders. In: Psychopharmacology. The third generation of progress (Ed. HY Meltzer), Raven Press, New York, 1987, 1021–1029. Honchar MP, Ackermann KE, Sherman WR. Chronically administered lithium alters neither myo-inositol mono-phosphatase activity nor phosphoinositide levels in rat brain. J Neurochem 1989, 53: 590–594. Hotta I, Yamawaki S, Segawa T. Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain. Neuropsychobiology 1986, 16: 19–26. Hotta I, Yamawaki S. Lithium decreases 5-HT1 receptors but increases 5-HT-sensitive adenylate cyclase activity in rat hippocampus. Biol Psychiatry 1986, 21: 1382–1390. Hsiao JK, Manji HK, Chen G, Bitran JA, Risby ED, Potter WZ. Lithium administration modulates platelet Gi in humans. Life Sci 1992, 50: 227–233. Ishibashi S, Kurokawa T, Higashi K, Dan'ura T. Regulation of the catalytic unit of adenylate cyclase system in rat brain. In: Neurotransmitter receptors. Mechanisms of action and regulation (Eds. SKT Segawa, K Kuriyama, HI Yamamura, RW Olsen), Plenum Press, New York, 1984, 63–74. Iyengar R. Hysteretic activation of adenylyl cyclases. II. Mg ion regulation of the activation of the regulatory component as analysed by reconstitution. J Biol Chem 1981, 256: 11042–11050. Iyengar R, Birnbaumer L. Hysteretic activation of adenylyl cyclases. I. Effect of Mg ion on the rate of activation by guanine nucleotides and fluoride. J Biol Chem 1981, 256: 11036–11041. Iyengar R, Birnbaumer L. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirements for Mg2+ and enhancing its extent of activation by guanine nucleotides. Proc Natl Acad Sci USA 1982, 79: 5179–5183. Jang H-K, Johnson MA, Canolty NL. Effects of lithium and casein intakes on growth, feed efficiency and organ weights of rats. Nutrition Reports Int 1989, 39: 703–711. Janowsky A Okada F, Manier D, Applegate CD, Sulser F. Role of serotonergic input in the regulation of the ß-adrenergic receptor-coupled adenylate cyclase system. Science 1982, 218: 900–901. Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Brit J Psychiatry 1971, 119: 267–276. Kanba S, Yagi G, Nakaki T, Kato R, Richelson E. Potentiation by a sodium channel activator of effects of lithium ion on cyclic AMP, cyclic GMP and inositol phosphates. Neuropharmacology 1991, 30: 497–500. Katada T, Bokoch GM, Smigel MD, Ui M, Gilman AG. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. J Biol Chem 1984, 259: 3586–3595. Katada T, Kusakabe K, Oinuma M, Ui M. A novel mechanism for the inhibition of adenylate cyclase via inhibitory GTP-binding proteins. J Biol Chem 1987, 262: 11897–11900. Kendall DA, Nahorski SR. Acute and chronic lithium treatments influence agonist and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. J Pharmacol Exp Ther 1987, 241: 1023–1027. Keogh R, Marley PD. Regulation of cyclic AMP levels by calcium in bovine adrenal medullary cells. J Neurochem 1991, 57: 1721–1728. Kirov GK, Tsachev KN. Magnesium, schizophrenia and manic-depressive disease. Neuropsychobiology 1990, 23: 79–81. Klein E, Patel J, McDevitt R, Zohar J. Chronic lithium treatment increases the phosphorylation of a 64-kDa protein in rat brains. Brain Res 1987, 407: 312–316. Koe BK, Koch SW, Lebet LA, Minor KW, Page MG. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain. Eur J Pharmacol 1987, 141: 187–194. Kofman O, Belmaker RH, Grisaru N, Alpert C, Fuchs I, Katz V, Rigler O. Myo-inositol attenuates two specific behavioral effects of acute lithium in rats. Psychopharmacol Bull 1991, 27: 185–189. Krall JF, Jamgotchian N. Forskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aorta. Biochem J 1987, 241: 463–467. Krupinski J, Coussen F, Bakalyar HA, Tang W-J, Feinstein PG, Orth K, Slaughter C, Reed RR, Gilman AG. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science 1989, 244: 1558–1564. Krupinski J. The adenylyl cyclase family. Mol Cell Biochem 1991, 104: 73–79. Lazarus JH. Lithium and the cell. In: Endocrine and metabolic effects of lithium. Plenum, New York 1986, 31–54. Leeb-Lundberg LMF, Cotecchia S, De Blasi A, Caron MG, Lefkowitz RJ. Regulation of adrenergic receptor function by
Publication Year: 1993
Publication Date: 1993-11-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 25
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot